BIOPTRAIN · Bioinformatics Optimisation Training
6РП — Действия „Мария Кюри“
- Период
- 2005-09-01 → 2009-08-31
- Финансиране от ЕС
- 2 121 547 €
- Участници
- 5
- Схема
- EST
Линиите свързват координатора с партньорите. За проекти отпреди 2014 г. CORDIS не винаги дава точни координати. Тези точки са на ниво град или държава.
Накратко на български
Биоинформатичните алгоритми се разработват, за да превръщат огромното количество генетични данни в полезна информация. Това помага за по-точна диагностика и персонализирано лечение на пациентите.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Final Activity Report Summary - BIOPTRAIN (Bioinformatics Optimisation Training)
Recent developments in genomic technologies imply that molecular biologists today have access to vast amounts of genetic data, and while this holds enormous potential in terms of guiding clinical decision-making, a number of issues remain to be addressed before the goal of personalised diagnosis and treatment for patients can be achieved. Data has to be turned into useful information if it is to be used in clinical science or to support clinical decision-making. As the technologies for producing bioinformatic data continue to advance, ever-more sophisticated computational algorithms are required to deal effectively with bioinformatic data. The BIOPTRAIN project addressed this need by training a set of young scientists in the range of skills necessary to deal with the specific problems related to the automated analysis of bioinformatic data, as well as by creating new algorithms suitable for the field. The four-year project provided a total of over 36 person-years of early-stage PhD training for a total of 12 long-term fellows, with posts longer than one year, and eight short-term fellows, with posts less than a year, distributed between four major European universities. The project was led in the United Kingdom by the University of Nottingham by Dr Garibaldi, in the KU Leuven Belgium by Profs. Moreau and De Causmaecker, in the University of Florence in Italy by Prof. Frasconi and, finally, in the Poznan University of Technology in Poland by Prof. Blazewicz. In line with the original aims and objectives of the project, the training was delivered across a wide range of fundamental techniques for analysing bioinformatics data and optimising the useful information able to be extracted from such data. Areas of training ranged from theoretical research into bioinformatic algorithms through to fundamental advances in the analysis of bioinformatic data, including: 1. computational and statistical analysis techniques to support clinical diagnosis and treatment of diseases. Fellows based at Nottingham, Leuven and Poznan received training in clinical areas such as classifying breast cancer, investigating genetic influences on pre-eclampsia and identifying genetic pathways in complex multi-genetic diseases such as Parkinson. 2. fundamental computational techniques for protein structure prediction and comparison, in which fellows at Florence and Nottingham received training. Long term potential applications included improved understanding of biomedical processes and novel therapeutic drug discovery. 3. methodological development of techniques for gene prioritisation and genetic characterisation, in which fellows at Leuven and Nottingham were trained. 4. theoretical and foundational developments for sequence analysis and other generic bioinformatic optimisation algorithms, in which fellows at Poznan, Florence and Nottingham were trained. Taken as a whole, the BIOPTRAIN programme resulted in 24 refereed journal publications, approximately another 24 international peer-reviewed conference publications and over 12 other forms of dissemination such as book chapters, web-services and software packages, with at least another 12 publications being either under submission or review by the time of its completion. This constituted an overall average of approximately two journal publications, two international peer-reviewed conference publications and one other miscellaneous dissemination, with another one submission under review, per thirty-six month, i.e. three-year, early-stage researcher. This was an outstanding level of achievement for the programme. In line with its aims, BIOPTRAIN also established successful, lasting collaboration between the four major partners, as evidenced through the establishment of the European computational biology, bioinformatics and medicine (EURO-CBBM) special interest group.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Completion of the sequencing of the entire human genome and other major technological advances in bioinformatics have opened up a huge range of scientific challenges that will need to be addressed in order to maintain Europe's scientific and commercial competitiveness and effectiveness in this emerging area of healthcare. An FP6 Network of Excellence, BIOPATTERN, has been established to integrate leading institutes around Europe to form a virtual institute for the study of individualised healthcare. The overall grand vision of BIOPATTERN is to integrate the analysis of nano-level bioinformatic data with micro level biosignal data and macro level patient information data in a pan-European cooperative research effort to combat major disease classes.Selected members of BIOPATTERN will form the core of the BIOPTRAIN EST, the aim of which is to establish a complementary wide-ranging training programme of world-class quality in bioinformatic optimisation algorithms. This will bring together academics from University of Nottingham (UK), University of Florence (Italy), Katholieke Universiteit Leuven (Belgium), University College of Boras (Sweden) and Poznan University of Technology (Poland) to form the necessary multi- and interdisciplinary team to deliver a programme narrow in focus (computational algorithms for optimisation of bioinformatic problems), yet broad in influence and perspective (with contributions from many disciplines including computer science, chemistry, biology, medicine, etc.).There are two crucial groups of beneficiaries:(i) the next generation of European scientists will be trained to take advantage of the latest advances in bioinformatics with an aim of creating a vibrant, future-proof and self-sustaining research effort; and(ii) the European citizen will be targeted to benefit from bioinformatics advances worldwide - we cannot depend on research communities in the USA and elsewhere to meet the specific needs of European healthcare.
Оригинален текст от CORDIS (на английски).
Участници
- UNIVERSITY OF NOTTINGHAM · NOTTINGHAMКоординаторОбединеното кралство
- HÖGSKOLAN I BORÅS (UNIVERSITY COLLEGE OF BORÅS) · BORÅSНиво градШвеция
- KATHOLIEKE UNIVERSITEIT LEUVEN · LEUVENБелгия
- POZNAN UNIVERSITY OF TECHNOLOGY · POZNANНиво градПолша
- UNIVERSITA DEGLI STUDI DI FIRENZE · FIRENZEИталия
Връзки
Данни: CORDIS, © Европейски съюз
